Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Transcenta Announced Successful First Patient Dosed in Phase I Clinical Study of TST001 Combined with CAPOX for the Treatment of Patients with First-line Locally Advanced Unresectable or Metastatic Gastric Cancer 2021-04-19 08:00
Kintor Pharmaceuticals Announced Successful Dosing of the First Batch of Patients for Acne Vulgaris Phase I/II Clinical Trial of Pyrilutamide 2021-04-16 18:29
Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China 2021-04-15 18:20
Harbour BioMed Presents Novel Antibody for Cancer Immunotherapy at 2021 American Association for Cancer Research Annual Meeting 2021-04-13 14:55
PharmAbcine presents the non-clinical data of PMC-309 at AACR 2021 2021-04-12 20:00
Yiling Pharmaceutical doubled its performance through innovation in 2020 2021-04-12 17:07
Gracell Biotechnologies Reports Long-term Follow-up Data on TruUCAR-enabled GC027 in Relapsed/Refractory T-ALL at the AACR 2021 Annual Meeting 2021-04-10 21:33
ImmVira Announces Preclinical and Clinical Data to Be Presented at the 2021 ASCO and AACR Annual Meeting 2021-04-08 20:47
Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-176 in EGFR-Mutant NSCLC with C797S 2021-04-07 06:00
Brattea, a Leading Renal Denervation Company in China, Completes over $US20 Million Series B+ Financing, led by Kuanping Capital 2021-04-06 20:00
MitoImmune Received FDA Clearance of IND Application for MIT-001, a Novel Anti-Inflammatory/Anti-Necrotic Therapy for Oral Mucositis in CCRT patients with Head and Neck Cancer 2021-04-06 20:00
US FDA Approved Jemincare to Initiate Clinical Trial of Neutralizing Antibody JMB2002 2021-04-02 13:40
Molecular Data Inc. intends to further upgrade its digital tools using Blockchain 2021-04-01 19:00
Yingli Pharma announce promising topline results of a Phase II registration study for treatment of relapsed/refractory follicular lymphoma with the once daily oral PI3Kδ inhibitor, linperlisib 2021-04-01 14:09
AffaMed Therapeutics and SIFI Announce Joint Venture to Serve Greater China Market 2021-03-31 19:30
3SBio announces 2020 annual results, tapping integrated platform advantages for steady growth 2021-03-31 09:11
AffaMed Therapeutics Announces Completion of over US$170 Million Series B Financing Led by Lake Bleu Capital to Further Development of Ophthalmic and Neuroscience Pipeline 2021-03-30 19:30
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020 2021-03-30 04:30
Fosun Pharma Announces 2020 Annual Results 2021-03-30 00:38
Tigermed Reports 2020 Annual Results With Solid Growth 2021-03-29 21:21
1 106 107 108 109 110 165